| HOME >> BIOLOGY >> TECHNOLOGY |
FIGURE 9 MULTI-TARGET KINASE INHIBITOR MARKET SHARE BY REGION, 2010 (%) 54
FIGURE 10 SERINE/THREONINE KINASE INHIBITOR MARKET SHARE BY REGION, 2010 (%) 55
FIGURE 11 MONOCLONAL ANTIBODY KINASE INHIBITOR MARKET SHARES BY REGION, 2010
(%) 56
FIGURE 12 GLOBAL MARKET FOR KINASE INHIBITORS BY APPLICATIONS, 2009-2016 ($
MILLIONS) 59
FIGURE 13 GLOBAL MARKET FOR KINASE INHIBITORS USED AS ANTINEOPLASTIC AGENTS,
2009-2016 ($ MILLIONS) 63
FIGURE 14 GLOBAL MARKET FOR KINASE INHIBITORS USED AS IMMUNOSUPPRESSANTS,
2009-2016 ($ MILLIONS) 64
FIGURE 15 GLOBAL MARKET FOR KINASE INHIBITORS USED IN AGE-RELATED MACULAR
DEGENERATION, 2009-2016 ($ MILLIONS) 66
FIGURE 16 GLOBAL MARKET SHARE OF APPLICATIONS OF KINASE INHIBITORS, 2010 (%) 67
FIGURE 17 U.S. MARKET FOR KINASE INHIBITORS, 2009-2016 ($ MILLIONS) 69
FIGURE 18 U.S. MARKET FOR TYROSINE KINASE INHIBITORS, 2009-2016 ($ MILLIONS) 71
FIGURE 19 U.S. MARKET FOR RECEPTOR TYROSINE KINASE INHIBITOR, 2009-2016 ($
MILLIONS) 74
FIGURE 20 U.S. MARKET FOR NON-RECEPTOR TYROSINE KINASE INHIBITOR, 2009-2016 ($
MILLIONS) 77
FIGURE 21 U.S. MARKET FOR MULTIKINASE TYROSINE INHIBITOR, 2009-2016 ($ MILLIONS) 80
FIGURE 22 U.S. MARKET FOR SERINE/THREONINE KINASE INHIBITOR, 2009-2016 ($
MILLIONS) 85
FIGURE 23 U.S. MARKET FOR MONOCLONAL ANTIBODY KINASE INHIBITOR 2009-2016 ($
MILLIONS) 88
FIGURE 24 U.S. MARKET SHARES OF RECEPTOR TYROSINE KINASE INHIBITOR
MANUFACTURERS, 2010 (%) 89
FIGURE 25 U.S. MARKET SHARES OF MULTI-TARGET KINASE INHIBITOR MANUFACTURERS,
2010 (%) 90
FIGURE 26 U.S. MARKET SHARES OF SERINE/ THREONINE KINASE INHIBITOR
MANUFACTURERS, 2010 (%) 91
FIGURE 27 U.S. MARKET SHARE OF ANTIBODY KINASE INHIBITOR MANUFACTURERS, 2010
(%) 92
FIGURE 28 U.S. MARKET FOR K
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |